CLINICAL_TRIALS trial_result · 2021-01-28

Clinical Trial Update: A Study Evaluating ABI-H0731 as Adjunctive Therapy in Participants With Chronic Hepatitis B Infection [Phase 2]

Phase 2 trial of ABI-H0731 as adjunctive therapy in chronic hepatitis B has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Assembly Biosciences | Conditions: Chronic Hepatitis B | Phase 2 | Status: COMPLETED | Results posted: 2021-01-28